Cargando…

Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review

Influenza is associated with an increased risk of complications, especially in diabetic mellitus patients who are more susceptible to influenza infection. Despite recommendations of the WHO and public health authorities, vaccination uptake in this population remains suboptimal. This systematic revie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dos Santos, Gael, Tahrat, Halima, Bekkat-Berkani, Rafik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149986/ https://www.ncbi.nlm.nih.gov/pubmed/29517396 http://dx.doi.org/10.1080/21645515.2018.1446719

Ejemplares similares

Seasonal influenza vaccination in patients with COPD: a systematic literature review
por: Bekkat-Berkani, Rafik, et al.
Publicado: (2017)

Influenza: Can we cope better with the unpredictable?
por: Dos Santos, Gaël, et al.
Publicado: (2015)

A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control
por: Ray, Riju, et al.
Publicado: (2017)

Vaccines against Meningococcal Diseases
por: Pizza, Mariagrazia, et al.
Publicado: (2020)

Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany
por: Molnar, Daniel, et al.
Publicado: (2022)

Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulations
por: Schmidt-Ott, Ruprecht, et al.
Publicado: (2019)

02. Beyond B Antigen Coverage: The Potential of the 4CMenB Vaccine for Cross-protection Against Pathogenic Neisseria Infections
por: Garcia, Yara Ruiz, et al.
Publicado: (2021)

A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine
por: Ruiz Garcia, Yara, et al.
Publicado: (2021)

Correction to: A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine
por: Ruiz Garcia, Yara, et al.
Publicado: (2021)

2319. Clinical Predictors of Influenza and Hospitalization of Children with Influenza in an Emergent Care Setting
por: Rao, Suchitra, et al.
Publicado: (2019)

Changing patterns of invasive meningococcal disease and future immunization strategies
por: Taha, Muhamed-Kheir, et al.
Publicado: (2023)

Meningococcal Disease Outbreaks: A Moving Target and a Case for Routine Preventative Vaccination
por: Soumahoro, Lamine, et al.
Publicado: (2021)

Range of invasive meningococcal disease sequelae and health economic application – a systematic and clinical review
por: Shen, Jing, et al.
Publicado: (2022)

Safety and immunogenicity of 3 seasonal trivalent influenza vaccines in the Chinese military
por: Gao, Dongqi, et al.
Publicado: (2016)

Determinants of Meningococcal Vaccination Coverage and Adherence: A Targeted Literature Review Supporting a 16-year-old Healthcare Visit
por: Herrera-Restrepo, Oscar, et al.
Publicado: (2023)

Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis
por: Dos Santos, Gael, et al.
Publicado: (2019)

Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations
por: Martinón-Torres, Federico, et al.
Publicado: (2021)

Passive enhanced safety surveillance of GSK’s quadrivalent seasonal influenza vaccine in Belgium, Germany and Spain, an observational study: protocol for the 2018/2019 influenza season
por: Dos Santos, Gaël, et al.
Publicado: (2019)

Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient‐reported outcome system for vaccine safety remote monitoring
por: Dos Santos, Gaël, et al.
Publicado: (2023)

986. Evaluation of Moderate-to-Severe Influenza Disease in Children 6 Months to 8 Years of Age in Colorado
por: Rao, Suchitra, et al.
Publicado: (2018)

Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
por: Murdoch, Louise, et al.
Publicado: (2023)

Brand-specific enhanced safety surveillance of GSK’s Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season
por: de Lusignan, Simon, et al.
Publicado: (2020)

Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis
por: de Lusignan, Simon, et al.
Publicado: (2018)

Retrospective study of the use of an influenza disease two-tiered classification system to characterize clinical severity in US children
por: Hsiao, Amber, et al.
Publicado: (2020)

Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
por: Carregaro, Rodrigo Luiz, et al.
Publicado: (2023)

Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season
por: Dos Santos, Gael, et al.
Publicado: (2019)

Post-authorisation passive enhanced safety surveillance of seasonal influenza vaccines: protocol of a pilot study in England
por: de Lusignan, Simon, et al.
Publicado: (2017)

Evaluation of immunogenicity of the 2008-2009 seasonal influenza vaccines by microneutralization test
por: Kim, Seung Youn, et al.
Publicado: (2012)

Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review
por: Boroumand, Amir Bahador, et al.
Publicado: (2022)

Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives
por: Dos Santos, Gaël
Publicado: (2019)

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older
por: Schwarz, Tino F, et al.
Publicado: (2017)

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
por: Jackson, Lisa A, et al.
Publicado: (2010)

Immunogenicity and safety of subunit influenza vaccines in pregnant women
por: Kostinov, Mikhail P., et al.
Publicado: (2018)

Safety and immunogenicity of synchronous COVID19 and influenza vaccination
por: Baj, Andreina, et al.
Publicado: (2022)

Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination
por: Wagenhäuser, Isabell, et al.
Publicado: (2023)

Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy
por: Walti, Carla S., et al.
Publicado: (2021)

Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto Butantan
por: Mondini, Gabriella, et al.
Publicado: (2018)

7. Two-Dose 4CMenB Vaccination in Adolescents Elicits a Bactericidal Activity against 15 Outbreak-Representative Meningococcal Strains
por: Biolchi, Alessia, et al.
Publicado: (2020)

Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect
por: Ruiz García, Yara, et al.
Publicado: (2021)

Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis
por: Remschmidt, Cornelius, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e6jmnv3oia059hquf5an7pgv4l